 TARRYTOWN, N.Y., May 27, 2021 GLOBE NEWSWIRE -- Prestige Consumer Healthcare Inc. Prestige or the Company NYSE:PBH today announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical company Akorn Operating Company LLC Akorn for 230 million in cash. The agreement is structured as an asset purchase that delivers anticipated tax benefits of 30 million and expected annual EBITDA of 20 million equating to a transaction valued at less than 10x pro-forma EBITDA. The transaction is estimated to add annual Revenues, Earnings Per Share and Operating Cash Flow of approximately 60 million, 0.10 and 13 million, respectively. 